Exploiting radiation immunostimulatory effects to improve glioblastoma outcome
Sign Up to like & getrecommendations! Published in 2022 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noac239
Abstract: Abstract Cancer treatment protocols depend on tumor type, localization, grade, and patient. Despite aggressive treatments, median survival of patients with Glioblastoma (GBM), the most common primary brain tumor in adults, does not exceed 18 months,… read more here.
Keywords: effects improve; immunostimulatory effects; radiation immunostimulatory; improve glioblastoma ... See more keywords